Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses ; volume:2 ; number:1 ; day:27 ; month:1 ; year:2014 ; pages:1-8 ; date:12.2014
Journal for ImmunoTherapy of Cancer ; 2, Heft 1 (27.1.2014), 1-8, 12.2014
- Urheber
-
Zloza, Andrew
- Beteiligte Personen und Organisationen
-
Kim, Dae Won
Kim-Schulze, Seunghee
Jagoda, Michael C.
Monsurrò, Vladia
Marincola, Francesco M.
Kaufman, Howard L.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-2-1
- URN
-
urn:nbn:de:1111-2016072656474
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zloza, Andrew
- Kim, Dae Won
- Kim-Schulze, Seunghee
- Jagoda, Michael C.
- Monsurrò, Vladia
- Marincola, Francesco M.
- Kaufman, Howard L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Oncolytic vaccinia therapy of squamous cell carcinoma
Oncolytic viruses for cancer immunotherapy
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Oncolytic vaccinia therapy of squamous cell carcinoma
Oncolytic viruses for cancer immunotherapy
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Oncolytic vaccinia therapy of squamous cell carcinoma
Oncolytic viruses for cancer immunotherapy
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Oncolytic Viruses: Priming Time for Cancer Immunotherapy